EFFECT OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN THE MANAGEMENT OF IRON DEFICIENCY ANEMIA, HOMOCYSTEINE (HCY) LEVELS AND CARDIAC FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)

被引：0
|
作者：
Vlachopanou, Afroditi [1 ]
Nikolopoulos, Petros [2 ]
Bampali, Theodora [1 ]
Foulidis, Valerios [1 ]
Katopodis, Konstantinos [1 ]
Gouva, Chariklia [1 ]
机构：
[1] Gen Hosp Arta, Arta, Greece
[2] Gen Hosp Syros, Syros, Greece
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SO053
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bregman, David B.
    Goodnough, Lawrence T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (02) : 48 - 60
  • [2] FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
    Macdougall, Iain C.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Roubert, Bernard
    Nolen, Jacqueline G.
    Roger, Simon D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (11) : 2075 - 2084
  • [3] Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bailie, George R.
    Mason, Nancy A.
    Valaoras, Thomas G.
    HEMODIALYSIS INTERNATIONAL, 2010, 14 (01) : 47 - 54
  • [4] EFFECT OF IV FERRIC CARBOXYMALTOSE ON PHYSICAL PERFORMANCE AND QOL IN PATIENTS WITH CKD NOT ON DIALYSIS, MILD ANEMIA AND IRON DEFICIENCY
    Puchades Montesa, Maria Jesus
    Casas Todoli, Juan
    Cases Amenos, Aleix
    Forquet, Claudia
    Gimenez-Civera, Elena
    Perez Bernat, Elisa
    Solano Rivera, Camila
    Muijsenberg Alcala, Andrea
    Acosta Barrios, Adriana
    Gorriz Teruel, Jose Luis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I593 - I593
  • [5] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON HEMATINIC AND RENAL FUNCTION VARIABLES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I379 - I380
  • [6] The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
    Koduru, Pramoda
    Abraham, Bincy P.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (01) : 76 - 85
  • [7] Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect
    Sanchez Gonzalez, Rebeca
    Guillermo Ternavasio-de la Vega, Hugo
    Moralejo Alonso, Leticia
    Ines Revuelta, Sandra
    Fuertes Martin, Aurelio
    MEDICINA CLINICA, 2015, 145 (03): : 108 - 111
  • [8] INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY
    Macdougall, I. D.
    Bock, A.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Roubert, B.
    Nolen, J.
    Roger, S. D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
  • [9] Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy
    Carla Rognoni
    Vittorio Ortalda
    Caterina Biasi
    Giovanni Gambaro
    Advances in Therapy, 2019, 36 : 3253 - 3264
  • [10] EFFECT OF INTRAVENOUS IRON REPLETION ON PLATELET COUNTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA
    Watkins, Madelynn
    Pal, Sangeeta
    Shirsat, Pallavi
    Dossabhoy, Rohinton N.
    Dossabhoy, Neville R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 596 - 596
12345